Rank N, Michel C, Haertel C, Lenhart A, Welte M, Meier-Hellmann A, Spies C
Department of Anesthesiology and Operative Intensive Care Medicine, University Hospital Benjamin Franklin, Freie Universität Berlin, Germany.
Crit Care Med. 2000 Dec;28(12):3799-807. doi: 10.1097/00003246-200012000-00006.
In septic shock, decreased splanchnic blood flow is reported, despite adequate systemic hemodynamics. Aacetylcysteine (NAC) was found to increase hepatosplanchnic blood flow in experimental settings. In septic shock patients, NAC improved the clearance of indocyanine green and the relationship of systemic oxygen consumption to oxygen demand. We investigated the influence of NAC on liver blood flow, hepatosplanchnic oxygen transport-related variables, and liver function during early septic shock.
Prospective, randomized, double-blind study.
Septic shock patients admitted to an interdisciplinary surgical intensive care unit.
We examined 60 septic shock patients within 24 hrs after onset of sepsis. They were conventionally resuscitated with volume and inotropes and were in stable condition. A gastric tonometer was inserted into the stomach and a catheter into the hepatic vein. Microsomal liver function was assessed by using the plasma appearance of monoethylglycinexylidide (MEGX).
Subjects randomly received either a bolus of 150 mg/kg iv NAC over 15 mins and a subsequent continuous infusion of 12.5 mg/kg/hr NAC over 90 mins (n = 30) or placebo (n = 30).
Measurements were performed before (baseline) and 60 mins after beginning the infusion (infusion). After NAC, a significant increase in absolute liver blood flow index (2.7 vs. 3.3 L/min/m2; p = .01) and cardiac index (5.0 vs. 5.7 L/min/m2; p = .02) was observed. Fractional liver blood flow index (cardiac index-related liver blood flow index) did not change. The difference between arterial and gastric mucosal carbon dioxide tension decreased (p = .05) and MEGX increased (p = .04). Liver blood flow index and MEGX correlated significantly (r(s) = .57; p < or = .01).
After NAC treatment, hepatosplanchnic flow and function improved and may, therefore, suggest enhanced nutritive blood flow. The increase of liver blood flow index was not caused by redistribution to the hepatosplanchnic area, but by an increase of cardiac index. Because of its correlation with liver blood flow index, MEGX may be helpful in identifying patients who benefit from NAC treatment in early septic shock.
在脓毒性休克中,尽管全身血流动力学正常,但据报道内脏血流减少。在实验环境中发现乙酰半胱氨酸(NAC)可增加肝内脏血流。在脓毒性休克患者中,NAC改善了吲哚菁绿的清除率以及全身氧消耗与氧需求的关系。我们研究了NAC在早期脓毒性休克期间对肝脏血流、肝内脏氧运输相关变量和肝功能的影响。
前瞻性、随机、双盲研究。
入住跨学科外科重症监护病房的脓毒性休克患者。
我们在脓毒症发作后24小时内检查了60例脓毒性休克患者。他们接受了常规的容量复苏和使用血管活性药物,病情稳定。将胃张力计插入胃内,并将导管插入肝静脉。通过单乙基甘氨酰二甲苯胺(MEGX)的血浆出现情况评估微粒体肝功能。
受试者随机接受在15分钟内静脉注射150mg/kg的NAC推注,随后在90分钟内持续输注12.5mg/kg/小时的NAC(n = 30)或安慰剂(n = 30)。
在输注开始前(基线)和输注60分钟后(输注)进行测量。给予NAC后,观察到绝对肝血流指数显著增加(2.7对3.3L/min/m²;p = 0.01)和心脏指数增加(5.0对5.7L/min/m²;p = 0.02)。肝血流分数指数(与心脏指数相关的肝血流指数)没有变化。动脉与胃黏膜二氧化碳分压之间的差异减小(p = 0.05),MEGX增加(p = 0.04)。肝血流指数与MEGX显著相关(r(s) = 0.57;p≤0.01)。
NAC治疗后,肝内脏血流和功能得到改善,因此可能提示营养性血流增加。肝血流指数的增加不是由于血流重新分布到肝内脏区域,而是由于心脏指数增加。由于MEGX与肝血流指数相关,它可能有助于识别在早期脓毒性休克中从NAC治疗中获益的患者。